Prostate cancer is a common disorder among elderly men [4], and the increased use of prostate-specific antigen (PSA) testing, along with increased life expectancy, has led to an increased incidence of prostate cancer diagnosis among this population category [5]. This evidence concerns the gene KLK3 and Familial prostate cancer.